HCL Technologies Limited has informed the Exchange regarding 'Grant of Restricted Stock Units ( RSUs )'.
HCLTECH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
HCL Technologies' Nomination and Remuneration Committee granted Restricted Stock Units (RSUs) to 58 eligible employees across the company and its subsidiaries under two employee stock plans — RSU Plan 2021 (10,860 RSUs to 11 employees) and RSU Plan 2024 (1,97,921 RSUs to 47 employees). In total, 2,08,781 RSUs were granted, translating to roughly 0.008% of paid-up equity share capital. The shares will be bought from the secondary market through a trust mechanism, so no fresh shares will be issued and there will be no EPS dilution. The exercise price is set at ₹2 per RSU (at par value), and vesting is spread across multiple dates between August 2026 and October 2028. Additionally, 68,844 previously approved RSUs (2,527 under Plan 2021 and 66,317 under Plan 2024) were cancelled.
Negligible impact for shareholders — the grant size is very small relative to total shares outstanding, and because shares are sourced from the open market rather than issued fresh, there is no dilution to earnings or existing shareholding.